首页> 外国专利> Chorionic somatomammotropin hormone splice variants

Chorionic somatomammotropin hormone splice variants

机译:绒毛膜促生长素激素剪接变体

摘要

The invention is based on the discovery that INSP100 is a splice variant of human chorionic somatomammotropin hormone 2 (HCS-B; Q14407) and that INSP104 is a splice variant of human chorionic somatomammotropin hormone 1 (hCS-A;P01243). The invention relates to the use of these proteins and nucleic acid sequences from the encoding genes in the diagnosis, prevention, and treatment of disease. ;This invention relates to novel proteins, termed INSP100 and INSP104, herein identified as novel splice variants of human Chorionic somatomammotropin hormone 2 (hCS-B; Q14407) and human Chorionic somatomammotropin hormone 1 (hCS-A; P01243) respectively and to the use of these proteins and nucleic acid sequences from the encoding genes in the diagnosis, prevention and treatment of disease. The variants have an altered A-B loop and are therefore predicted to possess altered receptor binding properties. All publications, patents and patent applications cited herein are incorporated in full by reference.
机译:本发明基于以下发现:INSP100是人绒毛膜促生长素激素2(HCS-B; Q14407)的剪接变体,而INSP104是人绒毛膜促生长素激素1(hCS-A; P01243)的剪接变体。本发明涉及来自编码基因的这些蛋白质和核酸序列在疾病的诊断,预防和治疗中的用途。 ;本发明涉及称为INSP 100 和INSP 104的新型蛋白质,在本文中被鉴定为人绒毛膜促生长素激素 2 (hCS的新型剪接变体-B; Q 14407 )和人绒毛膜促生长激素激素 1 (hCS-A; P 01243 ),以及这些蛋白和来自编码基因的核酸序列在疾病的诊断,预防和治疗中。所述变体具有改变的A-B环,因此被预测具有改变的受体结合性质。本文引用的所有出版物,专利和专利申请均通过引用全文并入。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号